| 000 | 01498 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513201658.0 | ||
| 264 | 0 | _c20000330 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0168-3659 | ||
| 024 | 7 |
_a10.1016/s0168-3659(99)00137-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMolema, G | |
| 245 | 0 | 0 |
_aThe use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapy. _h[electronic resource] |
| 260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cFeb 2000 |
||
| 300 |
_a229-39 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Bispecific _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Vessels _xdrug effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aEpitopes _xdrug effects |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasms _xtherapy |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xprevention & control |
| 700 | 1 | _aKroesen, B J | |
| 700 | 1 | _aHelfrich, W | |
| 700 | 1 | _aMeijer, D K | |
| 700 | 1 | _ade Leij, L F | |
| 773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 64 _gno. 1-3 _gp. 229-39 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0168-3659(99)00137-6 _zAvailable from publisher's website |
| 999 |
_c10595928 _d10595928 |
||